CrystalGenomics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
August 16, 2022 at 04:27 am EDT
Share
CrystalGenomics, Inc. reported earnings results for the second quarter and six months ended June 30, 2022. For the second quarter, the company reported sales was KRW 110.41 million compared to KRW 110.34 million a year ago. Net loss was KRW 6,013.05 million compared to net income of KRW 203.4 million a year ago. Basic loss per share from continuing operations was KRW 87 compared to basic earnings per share from continuing operations of KRW 3 a year ago. Diluted loss per share from continuing operations was KRW 87 compared to diluted earnings per share from continuing operations of KRW 3 a year ago. Basic loss per share was KRW 87 compared to basic earnings per share of KRW 3 a year ago.
For the six months, sales was KRW 280.17 million compared to KRW 182.11 million a year ago. Net loss was KRW 8,838.28 million compared to net income of KRW 1,134.29 million a year ago. Basic loss per share from continuing operations was KRW 128 compared to basic earnings per share from continuing operations of KRW 16 a year ago. Diluted loss per share from continuing operations was KRW 128 compared to diluted earnings per share from continuing operations of KRW 16 a year ago. Basic loss per share was KRW 128 compared to basic earnings per share of KRW 16 a year ago.
CG Invites Co Ltd is a Korea-based company principally engaged in the development and manufacturing of pharmaceuticals. The Company operates its business through three segments. The Pharmaceutical Research and Development segment is engaged in the research, development and sale of new drugs such as anti-inflammatory painkillers, anticancer drugs, anti-infectives and others. It is also engaged in the real estate rental business. The Pharmaceutical Manufacturing segment is engaged in the manufacture, retail and wholesale of finished drug products. The Other segment is engaged in the manufacture and sale of hot packs and other household items.
CRYSTALGENOMICS INVITES CO., LTD. 
